Orchestra BioMed Holdings Inc. (NASDAQ: OBIO) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ORCHESTRA BIOMED HOLDINGS INC.

Orchestra BioMed Holdings Inc. (NASDAQ: OBIO)
Listen to this Section


$3.96
+0.0950 ( +2.46% ) 107.0K

Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.

Market Data


Open $3.96
Previous Close $3.86
Volume 107.0K
Market Cap $231.14M
Day Range $3.80 - $4.00
52 Week Range $2.20 - $5.42
Shares Outstanding 59.88M
Change % +2.46%
Net Change ▲ 0.0950
Insider Ownership -0.35%
Exchange NASDAQ
SectorHealthcare
IndustryMedicinal Chemicals and Botanical Products
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 473,695.00

Date Type Amount Purchased Purchaser
2024-05-10 Sale -69333.00 Mika Yuval
2024-05-10 Sale -42000.00 Aiello Joshua
2024-03-28 Sale -10000.00 Pacitti David

SEC Filings


Form Type Description Pages Date
schedule Other 1 Nov 14, 2025
4 Insider transactions 1 Nov 14, 2025
8-k 8K-related 32 Nov 13, 2025
10-q Quarterly Reports 96 Nov 10, 2025
8-k 8K-related 37 Oct 30, 2025
8-k 8K-related 17 Oct 28, 2025
4 Insider transactions 1 Sep 19, 2025
4 Insider transactions 1 Sep 19, 2025
4 Insider transactions 1 Sep 19, 2025
4 Insider transactions 1 Sep 19, 2025

Latest News


× Before browsing our site, please accept our cookies policy